LMRI Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026
Revenue
272.0M
+3.0%
264.2M
+4.6%
252.5M
Cost of Revenue
225.6M
+0.1%
225.3M
+3.5%
217.8M
Gross Profit
46.4M
+19.4%
38.9M
+11.8%
34.8M
Operating Expenses
40.4M
+17.0%
34.5M
+14.0%
30.3M
R&D
0
0
0
SG&A
30.0M
+23.1%
24.4M
+20.0%
20.3M
Operating Income
6.0M
+37.5%
4.4M
-2.8%
4.5M
EBITDA
16.4M
+13.1%
14.5M
+0.2%
14.4M
Net Income
7.2M
+161.5%
2.7M
+59.9%
1.7M
EPS (Basic)
$0.07
+133.3%
$0.03
+50.0%
$0.02
EPS (Diluted)
$0.07
+133.3%
$0.03
+50.0%
$0.02
Shares (Diluted)
96.3M
+0.2%
96.0M
+0.1%
96.0M
Lumexa Imaging (LMRI) — Financials